In the News

Maryland Matters: Advocates ‘thrilled’ by state decision to cap spending on diabetes drug Jardiance

Danielle J. BrownApril 15, 2026 Excerpt: “Health care advocates on Wednesday hailed recent

In the News

Maryland Matters: Advocates push lawmakers to end tax break for drug commercials, advertising

March 12, 2026Maryland MattersDanielle J. Brown Excerpt: “Tired of seeing drug commercials on

In the News

Maryland Matters: Health care insurance is up, but rising costs drive thousands to select cheaper plans

Mayland MattersJanuary 24, 2026Danielle Brown Excerpt: “The number of people enrolling in

In the News

Maryland Matters: Officials, advocates push ‘Easy Enrollment’ box on tax forms amid rising health care costs

‘Easy Enrollment’ option may help some Marylanders secure more affordable health insurance as

In the News

Maryland Matters: Maryland board moves to set ceiling on what state will pay for Jardiance, Farxiga

Maryland MattersDanielle J. BrownNovember 17, 2025 EXCERPT: “The Maryland Prescription Drug

In the News

Maryland Matters: County leaders urge prescription drug board to set ‘upper payment limits’

September 30, 2025Maryland MattersDanielle Brown Excerpt: “County leaders urged the

In the News

Maryland Matters: Trump is back, so is watchdog board

By: Danielle J. Brown and William J. FordMaryland MattersSeptember 4, 2025 8:25 pm Excerpt: The

In the News

Maryland Matters: State board determines two Type 2 diabetes drugs may be unaffordable

Jardiance, Farxiga are the first drugs to complete PDAB’s cost review process, clearing the way

In the News

Maryland Matters Commentary: A Tale of Two Governors

Maryland MattersApril 8, 2025Op-Ed, Vincent DeMarco Excerpt: When Gov. Wes Moore adds his expected

In the News

House OKs parole reform, expanded PDAB gets senate approval and more political notes

Maryland MattersMarch 14, 2025Danielle Brown and William Ford Excerpt: Prescription drug board

In the News

Maryland Matters: Poll- Marylanders unconvinced lower drug costs would hinder research for new treatments

Maryland MattersJanuary 6, 2025Danielle J. Brown Excerpt: “A new poll says an overhwhelming

In the News

Maryland Matters: 2024 saw Medicaid unwinding, stalled projects moving, abortion rights affirmed

Maryland MattersDecember 28, 2024Danielle Brown Excerpt: PDAB selects drugs for cost review 2024

In the News

Maryland Matters: Maryland is taking steps to lower prescription drug prices; Big Pharma isn’t happy about it (Op-Ed)

Maryland Matters, Op-edNovember 15, 2024Glenn Schneider and Sean Tunis If the national election

In the News

Maryland Matters: Lawmakers OK upper payment limits for prescription drugs on state health plans

October 22, 2024Maryland MattersDanielle J. Brown Excerpt: “‘We’ve been waiting for

In the News

Maryland Matters: Board OKs upper payment limit process to cap drug costs on state health plans

September 10, 2024Maryland MattersDanielle J. Brown Excerpt: “The board early this

In the News

Law is helping people filing unemployment insurance claims get health care coverage

Maryland MattersMay 10, 2024Op-ed by Vincent DeMarco Excerpt: “The tragic collapse of the

In the News

Maryland Matters: Md. health officials have applied for new federal ‘AHEAD model.’ Here’s what it means.

Maryland MattersMarch 20, 2024Danielle J. Brown Excerpt: “The goal is to overcome systemic

In the News

Maryland Matters: A tidy crossover day produces progress and flashes of dissent

Maryland MattersMarch 19, 2024Josh Kurtz Excerpt: “The General Assembly will wait until 2025 to

In the News

PhRMA representatives say it’s ‘not the time’ to expand Prescription Drug Affordability Board authority

Maryland MattersDanielle J. BrownFebruary 13, 2024 Excerpt: Vincent DeMarco, president of Maryland

In the News

Report finds some drug manufacturers spend more on advertising, executives’ salaries than new research

Maryland MattersDanielle J. BrownJanuary 19, 2024 Excerpt: “The Number One argument that drug